Nomura Holdings’s Repros Therapeutics Inc. RPRX Stock Holding History

Nomura Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,900	Closed	-$17K	–	1928
2016 Q1	$17K	Buy	+17,900	New	+$17.5K	﹤0.01%	1495
2014 Q4	–	Sell	-55,535	Closed	-$576K	–	3153
2014 Q3	$576K	Sell	55,535 -10,131	-15%	-$150K	﹤0.01%	1726
2014 Q2	$1.13M	Buy	65,666 +195	+0.3%	+$3.18K	﹤0.01%	1388
2014 Q1	$1.16M	Buy	65,471 +199	+0.3%	+$3.85K	﹤0.01%	1414
2013 Q4	$1.2M	Buy	65,272 +40,039	+159%	+$756K	0.01%	916
2013 Q3	$679K	Sell	25,233 -21,265	-46%	-$456K	﹤0.01%	1240
2013 Q2	$858K	Buy	+46,498	New	+$821K	0.01%	1049

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Nomura Holdings's RPRX Position: Q2 2016 in Review

Nomura Holdings sold out of Repros Therapeutics Inc. (RPRX) in Q2 2016, closing a stake of 17,900 shares — an estimated $17K sold.

Nomura Holdings first reported a position in RPRX in Q2 2013 and held it in 7 quarters. The position peaked at $1.2M in Q4 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q2 2016.

Nomura Holdings reported no remaining Repros Therapeutics Inc. position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 17,900 Repros Therapeutics Inc. shares in Q2 2016, an estimated $17K.
Nomura Holdings first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 7 quarters.
Nomura Holdings's Repros Therapeutics Inc. position peaked at $1.2M in Q4 2013.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.